"A Reactive Oxygen Species-Scavenging ‘Stealth’ Polymer, Poly(thioglycidyl glycerol), Outperforms Poly(ethylene glycol) in Protein Conjugates and Nanocarriers and Enhances Protein Stability to Environmental and Biological Stressors"
Richard d’Arcy, Farah El Mohtadi, Nora Francini, Carlisle R. DeJulius, Hyunmoon Back, Arianna Gennari, Mike Geven, Maria Lopez-Cavestany, Zulfiye Yesim Turhan, Fang Yu, Jong Bong Lee, Michael R. King, Leonid Kagan, Craig L. Duvall, and Nicola Tirelli.
[1] Heo, Y.-A.; Syed, Y. Y.; Keam, S. J. Pegaspargase: A Review in Acute Lymphoblastic Leukaemia. Drugs 2019, 79, 767−777. [2] Armstrong, J. K.; Hempel, G.; Koling, S.; Chan, L. S.; Fisher, T.; Meiselman, H. J.; Garratty, G. Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients. Cancer 2007, 110, 103−111. [3] Kozma, G. T.; Mészáros, T.; Vashegyi, I.; Fülöp, T.; Ö rfi, E.; Dézsi, L.; Rosivall, L.; Bavli, Y.; Urbanics, R.; Mollnes, T. E.; Barenholz, Y.; Szebeni, J. Pse do-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions. ACS Nano 2019, 13, 9315−9324. [4] (a) Dadla, A.; Tannenbaum, S.; Yates, B.; Holle, L. Delayed hypersensitivity reaction related to the use of pegfilgrastim. J. Oncol. Pharm. Pract. 2015, 21, 474−477. (b) Povsic, T. J.; Lawrence, M. G.; Lincoff, A. M.; Mehran, R.; Rusconi, C. P.; Zelenkofske, S. L.; Huang, Z.; Sailstad, J.; Armstrong, P. W.; Steg, P. G.; Bode, C.; Becker, R. C.; Alexander, J. H.; Adkinson, N. F.; Levinson, A. I.; REGULATE-PCI Investigators. Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer. J. Allergy Clin. Immunol. 2016, 138, 1712−1715. [5] Hermanson, T.; Bennett, C. L.; Macdougall, I. C. Peginesatide for the treatment of anemia due to chronic kidney disease − an unfulfilled promise. Expert Opin Drug Saf. 2016, 15, 1421−1426. [6] Chen, B.-M.; Su, Y.-C.; Chang, C.-J.; Burnouf, P.-A.; Chuang, K.-H.; Chen, C.-H.; Cheng, T.-L.; Chen, Y.-T.; Wu, J.-Y.; Roffler, S. R. Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals. Anal. Chem. 2016, 88, 10661−10666. [7] Yang, Q.; Jacobs, T. M.; McCallen, J. D.; Moore, D. T.; Huckaby, J. T.; Edelstein, J. N.; Lai, S. K. Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population. Anal. Chem. 2016, 88, 11804−11812. [8] Ivens, I. A.; Achanzar, W.; Baumann, A.; Brändli-Baiocco, A.; Cavagnaro, J.; Dempster, M.; Depelchin, B. O.; Irizarry Rovira, A. R.; Dill-Morton, L.; Lane, J. H.; Reipert, B. M.; Salcedo, T.; Schweighardt, B.; Tsuruda, L. S.; Turecek, P. L.; Sims, J. PEGylated Biopharmaceuticals:Current Experience and Considerations for Nonclinical Development. Toxicol. Pathol. 2015, 43, 959−983. [9] Deng, Y.; Saucier-Sawyer, J. K.; Hoimes, C. J.; Zhang, J.; Seo, Y.E.; Andrejecsk, J. W.; Saltzman, W. M. The effect of hyperbranched polyglycerol coatings on drug delivery using degradable polymer nanoparticles. Biomaterials 2014, 35, 6595−6602. [10] Imran Ul-Haq, M.; Lai, B. F. L.; Chapanian, R.; Kizhakkedathu, J. N. Influence of architecture of high molecular weight linear and branched polyglycerols on their biocompatibility and biodistribution. Biomaterials 2012, 33, 9135−9147.